Occam Places Amgen CMO on Board of Moonwalk
In June 2025, Occam Global placed Paul Burton, MD, PhD, on the Board of Moonwalk Biosciences.
Burton became Amgen’s CMO in June 2023. Prior to joining Amgen, he served as the CMO of Moderna Therapeutics from 2021 to 2023 and spent 16 years at J&J, where his most recent role was Chief Global Medical Affairs Officer.
Burton has over 20 years of experience in the biopharmaceutical industry, covering all phases of drug discovery and development, including both small and large molecules, as well as mRNA therapeutics. He has also worked in various therapeutic areas, such as oncology, cardiovascular and metabolic diseases, and infectious diseases.
He earned his BSc in Physiology from King’s College London, his MD from the University of London, and his PhD in Philosophy from Imperial College London.
Read more about Occam's biotech board recruiting:
Bob D. Brown for Mammoth Biosiences
Occam Global is an international life science executive search and leadership advisory firm dedicated to building management teams for innovative companies in the biotech, techbio, life sciences, and venture capital sectors. Our firm’s unique strength lies in our seamless access to elite talent, proven expertise in aligning exceptional business and scientific leaders with optimal opportunities, and a steadfast dedication to creating meaningful industry impact, guided by elevated ethics and enlightened aggression. Trusted by entrepreneurs, investors, and corporations worldwide, Occam Global is recognized as the premier partner for executive search and recruitment in the life sciences. Our success is rooted in establishing trust, cultivating and valuing relationships, and committing to serve as forthright and good-humored partners in realizing extraordinary ambitions.